Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Armata Pharmaceuticals, Inc. (ARMP) Assets Average (2016 - 2018)

Armata Pharmaceuticals' Assets Average history spans 5 years, with the latest figure at $11.2 million for Q3 2018.

  • For Q3 2018, Assets Average fell 22.67% year-over-year to $11.2 million; the TTM value through Sep 2018 reached $11.2 million, down 22.67%, while the annual FY2017 figure was $14.6 million, N/A changed from the prior year.
  • Assets Average for Q3 2018 was $11.2 million at Armata Pharmaceuticals, down from $13.1 million in the prior quarter.
  • Across five years, Assets Average topped out at $39.4 million in Q1 2014 and bottomed at $11.2 million in Q3 2018.
  • The 5-year median for Assets Average is $28.2 million (2016), against an average of $25.0 million.
  • The largest annual shift saw Assets Average grew 5.7% in 2015 before it tumbled 48.89% in 2017.
  • A 5-year view of Assets Average shows it stood at $30.3 million in 2014, then increased by 16.36% to $35.2 million in 2015, then tumbled by 37.28% to $22.1 million in 2016, then tumbled by 43.61% to $12.5 million in 2017, then fell by 10.35% to $11.2 million in 2018.
  • Per Business Quant, the three most recent readings for ARMP's Assets Average are $11.2 million (Q3 2018), $13.1 million (Q2 2018), and $12.8 million (Q1 2018).